Abstract
Health care systems require high quality economic evaluations to support wise allocation decisions to enhance child health within the population served. LMICs face the added jeopardy of having very limited resources (human and fiscal) to produce complex economic evaluations within highly constrained healthcare budgets that demand judicious expenditure. Furthermore, conducting economic evaluations in children is challenging methodologically and this is exacerbated in LMICs where healthcare funding and health priorities are influenced by external forces. World Health Organization initiatives such as generalized cost-effectiveness analysis have addressed many of the pertinent methodological issues. However, of 49 economic evaluations of preventive interventions for children published in 2012, only 17 were relevant to LMIC. Of 25 economic evaluations of active pediatric treatments, only four targeted an LMIC population. Greater collaboration between health researchers from LMICs and high-income countries promises, in future, to improve the quality of evidence available for decision-making.
Keywords
- Economic Evaluation
- Human Papilloma Virus
- Health Economic Evaluation
- Improve Child Health
- Human Papilloma Virus Prevention
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Blaker D, Detsky A, Hubbard E, Kennedy W, Konchak R, Menon D, et al. Guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop on Pharmacoeconomics Steering Committee. Sainte-Adèle, Québec, Canada. 1994. p. 1–38.
Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J. 1992;146(4):473–91.
Aristides M, Mitchell A. Applying the Australian guidelines for the reimbursement of pharmaceuticals. Pharmacoeconomics. 1994;6(3):196–201.
Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ. 2004;329(7472):972–5.
Ungar WJ. Paediatric health economic evaluations: a world view. Healthc Q. 2006;10(1):134–40, 42–45.
Gauvreau CL, Ungar WJ, Kohler JC, Zlotkin S. The use of cost-effectiveness analysis for pediatric immunization in developing countries. Milbank Q. 2012;90(4):762–90.
NICE. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence; 2008. Report No.: N1618.
CADTH. Guidelines for the economic evaluation of health technologies: Canada. 3rd ed. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006.
Ungar WJ, Gerber A. The uniqueness of child health and the challenges to measuring costs and consequences. In: Ungar WJ, editor. Economic evaluation in child health. Oxford: Oxford University Press; 2010.
Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
Walker D, Fox-Rushby JA. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Econ. 2000;9(8):681–98.
UN. Reduce child mortality. Millennium development goals. United Nations Development Programme. 2011. http://www.beta.undp.org/content/undp/en/home/mdgoverview/mdg_goals/mdg4.html. Accessed 8 Oct 2014.
GAVI. GAVI disbursements to countries by type of support and year (2000 – Feb 28, 2014). Global alliance on vaccines and immunization. 2014. http://www.gavialliance.org/results/disbursements/. Accessed 8 Oct 2014.
Chee G, Hsi N, Carlson K, Chankova S, Taylor P. Evaluation of the first five years of GAVI immunization services support funding. Bethesda: Abt Associates; 2007.
Lu C, Michaud CM, Gakidou E, Khan K, Murray CJL. Effect of the global alliance for vaccines and immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment. Lancet. 2006;368(9541):1088–95.
Arevshatian L, Clements C, Lwanga S, Misore A, Ndumbe P, Seward J, et al. An evaluation of infant immunization in Africa: is a transformation in progress? Bull World Health Organ. 2007;85(6):449–57.
Walker DG, Beutels P, Hutubessy R. Economic evaluation of childhood vaccines. In: Ungar WJ, editor. Economic evaluation in child health. Oxford, UK: Oxford University Press; 2009. p. 211–23.
Cairns J. Discounting of children’s health: conceptual and practical difficulties. Economic valuation of environmental health risks to children. Paris: OECD; 2006. p. 187–205.
Ungar WJ. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated? Pharmacoeconomics. 2011;29(8):641–52.
Bank W. World development report 1993: investing in health, vol. 1. Washington, DC: World Bank; 1993.
Murray CJ, Acharya AK. Understanding DALYs (disability-adjusted life years). J Health Econ. 1997;16(6):703–30.
Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy RC, Acharya A, Evans DB, et al., editors. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003.
Hutubessy RC, Baltussen RM, Torres-Edejer TT, Evans DB. Generalised cost-effectiveness analysis: an aid to decision making in health. Appl Health Econ Health Policy. 2002;1(2):89–95.
Hutubessy RC, Chisholm D, Torres-Edejer TT. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc. 2003;1:8.
World Health Organization. http://www.who.int/choice/results/en/. 2010. Accessed 8 Oct 2014.
Adam T, Lim SS, Mehta S, Bhutta ZA, Fogstad H, Mathai M, et al. Achieving the millennium development goals for health cost effectiveness analysis of strategies for maternal and neonatal health in developing countries. BMJ. 2005;331(7525):1107–10.
Evans DB, Tan-Torres Edejer T, Adam T, Lim SS. Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ. 2005;331(7525):1137–40.
Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ. 2005;331(7530):1431–7.
Morel CM, Lauer JA, Evans DB. Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ. 2005;331(7528):1299 [erratum appears in BMJ. 2006;332(7534):151].
Tan-Torres Edejer T, Aikins M, Black R, Wolfson L, Hutubessy R, Evans DB. Cost effectiveness analysis of strategies for child health in developing countries. BMJ. 2005;331(7526):1177.
Ungar WJ, Santos MT. The Pediatric Economic Database Evaluation (PEDE) Project: establishing a database to study trends in pediatric economic evaluation. Med Care. 2003;41(10):1142–52.
PEDE. Pediatric Economic Database Evaluation (PEDE) Project. The hospital for sick children, Toronto. 2014. http://pede.ccb.sickkids.ca/pede/index.jsp. Accessed 8 Oct 2014.
Kromm SK, Bethell J, Kraglund F, Edwards SA, Laporte A, Coyte PC, et al. Characteristics and quality of pediatric cost-utility analyses. Qual Life Res. 2012;21(8):1315–25.
World Health Organization. World health statistics, 2010. Department of Health Statistics and Informatics of the Information, Evidence and Research Cluster. Geneva, Switzerland; 2010. http://www.who.int/gho/publications/world_health_statistics/EN_WHS10_Full.pdf?ua=1. Accessed 2 March 2015.
Acknowledgments
In-kind support was provided by The Hospital for Sick Children Research Institute. The assistance of Nadine Francis is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ungar, W.J., Zur, R.M. (2015). Health Economic Evaluation for Improving Child Health in Low- and Middle-Income Countries. In: MacLeod, S., Hill, S., Koren, G., Rane, A. (eds) Optimizing Treatment for Children in the Developing World. Adis, Cham. https://doi.org/10.1007/978-3-319-15750-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-15750-4_19
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-15749-8
Online ISBN: 978-3-319-15750-4
eBook Packages: MedicineMedicine (R0)